Clinical Trials Sponsored by Tibion Bionics, Inc.
Total 627 results
-
Notal Vision Ltd.CompletedAMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular EdemaIsrael
-
Notal Vision Ltd.WithdrawnAge Related Macular Degeneration | Choroidal NeovascularizationFrance
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationUnited States
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationUnited States
-
Notal Vision Ltd.CompletedAge Related Macular Degeneration
-
Notal Vision Ltd.CompletedAge Related Macular Degeneration | Choroidal NeovascularizationUnited States
-
Notal Vision Ltd.CompletedAge Related Macular Degeneration | Choroidal NeovascularizationUnited States
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.Completed
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.CompletedAge Related Macular Degeneration
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.CompletedA. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF TreatmentIsrael
-
Notal Vision Ltd.CompletedAge-Related Macular Degeneration | Diabetic RetinopathyIsrael
-
Notal Vision Ltd.CompletedAge-Related Macular DegenerationUnited States
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
Notal Vision Ltd.Completed
-
Notal Vision Ltd.CompletedAge Related Macular DegenerationIsrael
-
BiogenIonis Pharmaceuticals, Inc.Active, not recruitingParkinson's DiseaseUnited States, Spain, Israel, Canada, Norway, United Kingdom
-
Ionis Pharmaceuticals, Inc.AstraZenecaActive, not recruitingTransthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)United States, Spain
-
BiogenIonis Pharmaceuticals, Inc.Active, not recruitingALS Caused by Superoxide Dismutase 1 (SOD1) MutationUnited States, Canada, Italy, Belgium, New Zealand, Japan, France, Germany, United Kingdom
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Spain
-
GlaxoSmithKlineIonis Pharmaceuticals, Inc.CompletedHepatitis B | Chronic Hepatitis B AtypicalKorea, Republic of, Hong Kong
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Ionis Pharmaceuticals, Inc.AnapharmCompletedInflammatory DiseasesCanada
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Ribon Therapeutics, Inc.Active, not recruitingAdvanced Squamous Non-Small Cell Lung CarcinomaUnited Kingdom, United States, Israel, Spain
-
Ribon Therapeutics, Inc.RecruitingSolid Tumor, AdultUnited States, Spain
-
Advanced Vision Science, Inc.Active, not recruitingCataractPortugal, United Kingdom, France
-
ACE Vision Group, Inc.Terminated
-
Sunhawk Vision Biotech, Inc.Completed
-
Sunhawk Vision Biotech, Inc.Not yet recruiting
-
ACE Vision Group, Inc.Active, not recruiting
-
Dreamhawk Vision Biotech, Inc.CompletedDry Eye DiseaseThailand, Australia, Taiwan
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemiaUnited States, Canada, France, Germany, United Kingdom, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.TerminatedFamilial Partial LipodystrophyUnited States, Netherlands, Belgium, Brazil, Canada, Germany, Russian Federation
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Partial LipodystrophyUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedHypertriglyceridemia | Familial HypercholesterolemiaCanada
-
Elizabeth J FranzmannAveta Biomics, Inc.RecruitingOropharyngeal Dysplasia | Oral Cavity Dysplasia | Oral Carcinoma in SituUnited States
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Brazil, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, South Africa, Spain, United Kingdom
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedCardiovascular Disease | Elevated Lipoprotein(a)United States, Canada, Denmark, Germany, Netherlands